| Ditemukan 268 dokumen dengan kata kunci 9167 |
Simpan CSV  |
|
Run-In Phase III Trial Design With Pharmacodynamics Predictive Biomarkers
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.21, 6 November 2013: p.1628-1633 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial
|
|
|
|
Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.23, 4 December 2013: p.1789-1798 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial
|
|
|
|
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
|
|
|
|
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†
|
|
|
|
Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
|
|
|
|
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.22, 20 November 2013: p.1677-1683 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|
|
|
|
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
|
|
|
Hasil Pencarian
